Amyloid-β probes: Review of structure–activity and brain-kinetics relationships

Scholarly Works

• Imran, K.; Dhamapurkar, Y. A.; Sharma, A. Fluorescent Organic Molecules as Diagnostic and Theranostic Tools for Alzheimer's Disease. Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease; Springer Nature Singapore, 2023; pp 93–131. doi:10.1007/978-981-99-6038-5_5
• Rai, H.; Singh, R.; Bharti, P.; Kumar, P.; Rai, S.; Varma, T.; Chauhan, B. S.; Nilakhe, A.; Debnath, J.; Mishra, V.; Gupta, S.; Krishnamurthy, S.; Yang, J.; Garg, P.; Srikris, S.; Kumar, S.; Modi, G. Rhodanine composite fluorescence probes to detect amyloid-beta aggregated species in Alzheimer's disease models. Research Square Platform LLC 2023. doi:10.21203/rs.3.rs-2721179/v1
• Rai, H.; Gupta, S.; Kumar, S.; Yang, J.; Singh, S. K.; Ran, C.; Modi, G. Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease. Journal of medicinal chemistry 2022, 65, 8550–8595. doi:10.1021/acs.jmedchem.1c01619
• Huynh, T. T.; Wang, Y.; Terpstra, K.; Cho, H.-J.; Mirica, L. M.; Rogers, B. E. 68Ga-Labeled Benzothiazole Derivatives for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy. ACS omega 2022, 7, 20339–20346. doi:10.1021/acsomega.2c02369
• Kim, B.; Jha, S.; Seo, J. H.; Jeong, C.-H.; Lee, S.; Lee, S.; Seo, Y. H.; Park, B. MeBib Suppressed Methamphetamine Self-Administration Response via Inhibition of BDNF/ERK/CREB Signal Pathway in the Hippocampus. Biomolecules & therapeutics 2020, 28, 519–526. doi:10.4062/biomolther.2020.041
• Pravin, N.; Kumar, R.; Tripathi, S.; Kumar, P.; Mohite, G. M.; Navalkar, A.; Panigrahi, R.; Singh, N.; Gadhe, L. G.; Manchanda, S.; Shimozawa, M.; Nilsson, P.; Johansson, J.; Kumar, A.; Maji, S. K.; Shanmugam, M. Benzimidazole-based fluorophores for the detection of amyloid fibrils with higher sensitivity than Thioflavin-T. Journal of neurochemistry 2020, 156, 1003–1019. doi:10.1111/jnc.15138
• Kaur, A.; New, E. J.; Sunde, M. Strategies for the Molecular Imaging of Amyloid and the Value of a Multimodal Approach. ACS sensors 2020, 5, 2268–2282. doi:10.1021/acssensors.0c01101
• Choi, G.; Kim, H.-K.; Baek, A. R.; Kim, S.; Kim, M. J.; Kim, M.; Cho, A. E.; Lee, G. H.; Jung, H.; Yang, J.-u.; Lee, T.; Chang, Y. Multifunctional imaging of amyloid-beta peptides with a new gadolinium-based contrast agent in Alzheimer’s disease. Journal of Industrial and Engineering Chemistry 2020, 83, 214–223. doi:10.1016/j.jiec.2019.11.031
• Choi, M. A.; Park, S. Y.; Chae, H. Y.; Song, Y.; Sharma, C.; Seo, Y. H. Design, synthesis and biological evaluation of a series of CNS penetrant HDAC inhibitors structurally derived from amyloid-β probes. Scientific reports 2019, 9, 13187. doi:10.1038/s41598-019-49784-9
• Mourtas, S.; Christodoulou, P.; Klepetsanis, P.; Gatos, D.; Barlos, K.; Antimisiaris, S. G. Preparation of Benzothiazolyl-Decorated Nanoliposomes. Molecules (Basel, Switzerland) 2019, 24, 1540. doi:10.3390/molecules24081540
• Green, K. D.; Fosso, M. Y.; Garneau-Tsodikova, S. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors. Molecules (Basel, Switzerland) 2018, 23, 3252. doi:10.3390/molecules23123252
• Fändrich, M.; Nyström, S.; Nilsson, K.-F.; Böckmann, A.; LeVine, H.; Hammarström, P. Amyloid fibril polymorphism: a challenge for molecular imaging and therapy. Journal of internal medicine 2018, 283, 218–237. doi:10.1111/joim.12732
• Josephson, L.; Stratman, N. C.; Liu, Y.; Qian, F.; Liang, S. H.; Vasdev, N.; Patel, S. The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils. Molecular imaging 2018, 17, 1536012118796297. doi:10.1177/1536012118796297
• Alves, F.; Bode, J.; Cimalla, P.; Hilger, I.; Hofmann, M.; Jaedicke, V.; Koch, E.; Licha, K.; Rademakers, T.; Razansky, D.; van Zandvoort, M. A. M. J. Optical Imaging. Small Animal Imaging; Springer International Publishing, 2017; pp 403–490. doi:10.1007/978-3-319-42202-2_16
• Bolognesi, M. From Imaging Agents to Theranostic Drugs in Alzheimer’s Disease. Comprehensive Medicinal Chemistry III; Elsevier, 2017; Vol. 1, pp 74–106. doi:10.1016/b978-0-12-409547-2.12285-1
• Nigam, S.; Jayashree, B. S. Limitation of Algar–Flynn–Oyamada reaction using methoxy substituted chalcones as reactants and evaluation of the newly transformed aurones for their biological activities. Research on Chemical Intermediates 2016, 43, 2839–2864. doi:10.1007/s11164-016-2797-z
• Walji, A.; Hostetler, E. D.; Selnick, H. G.; Zeng, Z.; Miller, P.; Bennacef, I.; Salinas, C.; Connolly, B.; Gantert, L.; Holahan, M. A.; O'Malley, S.; Purcell, M.; Riffel, K.; Li, J.; Balsells, J.; O'Brien, J. A.; Melquist, S.; Soriano, A.; Zhang, X.; Ogawa, A.; Xu, S.; Joshi, E.; Della Rocca, J.; Hess, F.; Schachter, J. B.; Hesk, D.; Schenk, D. J.; Struyk, A.; Babaoglu, K.; Lohith, T. G.; Wang, Y.; Yang, K.; Fu, J.; Evelhoch, J. L.; Coleman, P. J. Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs). Journal of medicinal chemistry 2016, 59, 4778–4789. doi:10.1021/acs.jmedchem.6b00166.s001
• Heo, C. H.; Sarkar, A. R.; Baik, S. H.; Jung, T. S.; Kim, J. J.; Kang, H.; Mook-Jung, I.; Kim, H. M. A quadrupolar two-photon fluorescent probe for in vivo imaging of amyloid-β plaques. Chemical science 2016, 7, 4600–4606. doi:10.1039/c6sc00355a
• LeVine, H.; Walker, L. C. What amyloid ligands can tell us about molecular polymorphism and disease. Neurobiology of aging 2016, 42, 205–212. doi:10.1016/j.neurobiolaging.2016.03.019
• Pan, M.-L.; Mukherjee, M.; Patel, H.; Patel, B.; Constantinescu, C.; Mirbolooki, M. R.; Liang, C.; Mukherjee, J. Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT. Synapse (New York, N.Y.) 2016, 70, 163–176. doi:10.1002/syn.21893

Explore citations to this article at